Tempus AI (TEM Quick QuoteTEM - Free Report) reported $314.64 million in revenue for the quarter ended June 2025, representing a year-over-year increase of 89.6%. EPS of -$0.22 for the same period compares to -$0.63 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $299.32 million, representing a surprise of +5.12%. The company delivered an EPS surprise of +4.35%, with the consensus EPS estimate being -$0.23.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Tempus performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net Revenue- Data and services: $72.79 million versus the four-analyst average estimate of $73.93 million.
• Net Revenue- Genomics: $241.84 million versus the four-analyst average estimate of $224.3 million.
• Non-GAAP Gross Profit- Genomics: $143.76 million versus the three-analyst average estimate of $129.5 million.
• Non-GAAP Gross Profit- Data and Services: $53.76 million compared to the $53.46 million average estimate based on three analysts.

View all Key Company Metrics for Tempus here>>>

Shares of Tempus have returned -1.4% over the past month versus the Zacks S&P 500 composite's +1.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.